AJOONI BIOTECH
|
AJOONI BIOTECH Last 5 Year Financial Ratios History
[Standalone]
| Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 0.25 | 0.13 | 1.05 | 0.37 | 0.41 |
| CEPS(Rs) | 0.35 | 0.24 | 0.43 | 0.19 | 0.18 |
| DPS(Rs) | - | - | - | - | - |
| Book NAV/Share(Rs) | 4.87 | 4.76 | 16.37 | 15.50 | 18.57 |
| Tax Rate(%) | 27.87 | 28.67 | 28.22 | 26.02 | 27.86 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 2.79 | 3.71 | 4.15 | 3.23 | 3.02 |
| EBIT Margin(%) | 4.43 | 2.76 | 2.70 | 2.13 | 2.02 |
| Pre Tax Margin(%) | 3.74 | 2.12 | 1.97 | 0.99 | 1.20 |
| PAT Margin (%) | 2.70 | 1.51 | 1.42 | 0.73 | 0.87 |
| Cash Profit Margin (%) | 3.79 | 2.86 | 2.92 | 1.86 | 2.10 |
| Performance Ratios | |||||
| ROA(%) | 4.09 | 2.58 | 3.70 | 1.47 | 1.69 |
| ROE(%) | 5.12 | 3.87 | 6.58 | 2.40 | 2.54 |
| ROCE(%) | 7.75 | 5.99 | 9.09 | 5.07 | 4.35 |
| Asset Turnover(x) | 1.52 | 1.71 | 2.61 | 2.01 | 1.95 |
| Sales/Fixed Asset(x) | 6.45 | 7.91 | 10.46 | 11.84 | 15.22 |
| Working Capital/Sales(x) | 2.73 | 3.83 | 6.24 | 4.66 | 3.43 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.15 | 0.13 | 0.10 | 0.08 | 0.07 |
| Receivable days | 76.34 | 84.26 | 67.91 | 94.23 | 79.67 |
| Inventory Days | 50.94 | 31.55 | 27.75 | 30.97 | 38.09 |
| Payable days | 30.34 | 46.94 | 34.78 | 31.11 | 16.19 |
| Valuation Parameters | |||||
| PER(x) | 21.09 | 27.12 | 11.32 | 14.38 | 2.92 |
| PCE(x) | 15.01 | 14.33 | 24.24 | 24.88 | 5.92 |
| Price/Book(x) | 1.07 | 0.73 | 3.20 | 1.52 | 0.32 |
| Yield(%) | - | - | - | - | - |
| EV/Net Sales(x) | 0.67 | 0.53 | 0.98 | 0.72 | 0.28 |
| EV/Core EBITDA(x) | 12.07 | 12.90 | 23.34 | 22.19 | 8.68 |
| EV/EBIT(x) | 15.04 | 19.21 | 36.29 | 33.96 | 13.96 |
| EV/CE(x) | 1.19 | 0.84 | 3.34 | 1.66 | 0.55 |
| M Cap / Sales | 0.65 | 0.46 | 0.91 | 0.60 | 0.16 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 7.55 | 0.61 | 45.06 | 27.49 | 0.79 |
| Core EBITDA Growth(%) | 44.68 | -1.67 | 86.81 | 28.08 | 24.57 |
| EBIT Growth(%) | 72.89 | 2.69 | 83.88 | 34.59 | 33.45 |
| PAT Growth(%) | 92.16 | 7.24 | 181.14 | 7.57 | -15.62 |
| EPS Growth(%) | 92.13 | -87.75 | 181.14 | -9.64 | -38.20 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.05 | 0.12 | 0.33 | 0.44 | 0.32 |
| Current Ratio(x) | 10.74 | 2.28 | 2.18 | 2.05 | 3.00 |
| Quick Ratio(x) | 5.63 | 1.82 | 1.60 | 1.53 | 2.43 |
| Interest Cover(x) | 6.38 | 4.30 | 3.71 | 1.86 | 2.47 |
| Total Debt/Mcap(x) | 0.04 | 0.15 | 0.08 | 0.22 | 0.79 |
Compare Financial Ratios of peers of AJOONI BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AJOONI BIOTECH | ₹102.3 Cr | -1.2% | NA | 1.7% | Stock Analytics | |
| GODREJ AGROVET | ₹12,780.2 Cr | -13.5% | -12.5% | 41.9% | Stock Analytics | |
| WATERBASE | ₹201.2 Cr | -2.5% | -0.3% | -36.3% | Stock Analytics | |
AJOONI BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AJOONI BIOTECH | -1.2% |
NA |
1.7% |
| SENSEX | 0.9% |
4.2% |
8.3% |
You may also like the below Video Courses
